Polynovo Ltd has released a press release.
BARDA funding for Pivotal Trial
Filed with ASX ·
Watch Polynovo's latest callPolynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Story so far
Earlier from Polynovo
- Trading Update
- Pivotal Trial Protocol - Update
- Appt Brennan as MD PNV
- Feasibility Study Results Summary
- Debt Finance Facility
Later from Polynovo
- Appendix 4E and FY20 Annual Report
- FY20 Results Presentation
- Appointment of distributor for Finland
- Taiwan FDA Approval for PolyNovo
- USA FDA approves Pivotal Trial IDE
Follow Polynovo into a list and get an email when it puts out news.
Follow Polynovo